JPH0919298A - Assay using new bilirubin oxidase - Google Patents

Assay using new bilirubin oxidase

Info

Publication number
JPH0919298A
JPH0919298A JP8189379A JP18937996A JPH0919298A JP H0919298 A JPH0919298 A JP H0919298A JP 8189379 A JP8189379 A JP 8189379A JP 18937996 A JP18937996 A JP 18937996A JP H0919298 A JPH0919298 A JP H0919298A
Authority
JP
Japan
Prior art keywords
bilirubin
biliverdin
oxidase
molecules
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8189379A
Other languages
Japanese (ja)
Other versions
JP2901231B2 (en
Inventor
Mamoru Takahashi
守 高橋
Shigeyuki Imamura
茂行 今村
Masaki Takada
正樹 高田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd filed Critical Asahi Chemical Industry Co Ltd
Priority to JP8189379A priority Critical patent/JP2901231B2/en
Publication of JPH0919298A publication Critical patent/JPH0919298A/en
Application granted granted Critical
Publication of JP2901231B2 publication Critical patent/JP2901231B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a usage of bilirubin oxidase catalyzing the reaction to produce biliverdin and water from bilirubin and oxygen. SOLUTION: Bilirubin oxidase is made to act on a specimen to convert the bilirubin in the specimen into biliverdin, which is then quantified, or the oxygen consumed is determined, thus assaying the bilirubin in the specimen. The bilirubin oxidase has the following characteristics: having substrate specificity to bilirubin; having no substrate specificity to at least biliverdin, catechol and hemin; and catalyzing an enzymatic reaction to produce two molecules of biliverdin and two molecules of water from two molecules of bilirubin and one molecule of oxygen. Therefore, the bilirubin oxidase is useful for diagnosing hepatopathy and scavenging bilirubin when the bilirubin in a specimen during clinical diagnosis hampers the assay of other substance(s), and can also be used for decoloring human waste treatment water because of its extremely high activity.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、新規なビリルビン
・オキシダーゼを用いた測定法および検体中のビリルビ
ンを消去する方法に関する。
TECHNICAL FIELD The present invention relates to a novel assay method using bilirubin oxidase and a method for eliminating bilirubin in a sample.

【0002】[0002]

【従来の技術】ビリルビン・オキシダーゼは、ビリルビ
ンおよび酸素からビリベルジンと水を生成する反応を触
媒する酵素であり、従来より、ミロセシウム属(特開昭
60−12032号)、バチルス属(特開昭61−20
9587号)、スエヒロタケ属(特開昭59−1358
86号)、コプリナス属、トラメテス属、コリオラマ
属、フォリオタ属、プロイロタス属、レンジデス属、フ
シドプシス属(特開昭59−198971号)、ナス
科、バショウ科、ユリ科(特開昭60−78580号)
などが由来する酵素が知られている。
Bilirubin oxidase is an enzyme that catalyzes the reaction of producing biliverdin and water from bilirubin and oxygen, and has been conventionally found in the genus Milocesium (JP-A-60-12032) and the genus Bacillus (JP-A-61-12032). -20
9587) and the genus Suehirotake (Japanese Patent Laid-Open No. 59-1358).
86), Coprinus genus, Trametes genus, Coriorama genus, Foliota genus, Proirotas genus, Rangedes genus, Fusidopsis genus (Japanese Patent Laid-Open No. 59-198971), Solanaceae, Basaceae, Lily family (Japanese Patent Laid-Open No. 60-78580). )
The enzyme derived from is known.

【0003】ビリルビンは、ヘモグロビンの分解によつ
て血中に形成される黄色物質であり、肝臓で作られる胆
汁の主色素である。血清中には抱合ビリルビン及び遊離
ビリルビンが存在し、血清中の抱合ビリルビンの増加か
ら、肝ミクロゾームにおける抱合から十二指腸までのビ
リルビン運搬系の障害をきたしたことから、また血清中
の遊離ビリルビンの増加からは、種々の原因によって生
ずる溶血性貧血等を生じたことを示し、抱合及び/又は
遊離ビリルビンを定量することは臨床的に極めて重要で
ある。さらに、被検体サンプル中のビリルビンレベルを
積極的に低下させるために、ビリルビン・オキシダーゼ
は非常に有用である。
Bilirubin is a yellow substance formed in the blood by the decomposition of hemoglobin and is the main pigment of bile produced in the liver. Conjugated bilirubin and free bilirubin were present in the serum, and increased serum conjugated bilirubin, impaired bilirubin delivery system from conjugation to duodenum in liver microsomes, and increased serum free bilirubin Indicates that hemolytic anemia or the like caused by various causes has occurred, and it is extremely important clinically to determine conjugated and / or free bilirubin. Furthermore, bilirubin oxidase is very useful for actively reducing bilirubin levels in analyte samples.

【0004】[0004]

【発明が解決しようとする課題】上記したような従来公
知のビリルビン・オキシダーゼは、基質特異性が低く、
そのために例えば臨床化学分野で使用するには問題があ
った。即ち、上記した公知の微生物由来のビリルビン・
オキシダーゼは、全てビリベルジンにも基質特異性を有
しており、ビリルビンの分析には適していなかった。ま
た、植物由来の酵素は、原料に季節的な要因をはじめと
する種々の制約があり、工業的には有利とは言えない
し、その基質特異性についてもナス科のものは、ビリベ
ルジン、ヘモグロビンには作用しないことを示してい
る、と述べられているが、その他の基質については何も
開示されておらない。このように、公知のビリルビン・
オキシダーゼは、テトラピロール構造を持つ物質あるい
はフエノール系物質に作用するため、臨床検査分野にお
ける血液生化学検査に用いる場合、夾雑する他の組成物
に大きく影響されるという欠点があった。
The above-mentioned conventionally known bilirubin oxidase has a low substrate specificity,
Therefore, there was a problem in using it in the field of clinical chemistry, for example. That is, the above-mentioned known microbial-derived bilirubin
All oxidases also had substrate specificity for biliverdin and were not suitable for bilirubin analysis. In addition, plant-derived enzymes are not industrially advantageous because there are various restrictions such as seasonal factors in the raw materials, and the solanaceae of the Solanaceae family are limited to biliverdin and hemoglobin. Does not work, but does not disclose anything about the other substrates. Thus, known bilirubin
Since oxidase acts on a substance having a tetrapyrrole structure or a phenol-based substance, it has a drawback that it is greatly affected by other contaminating compositions when used in blood biochemical tests in the clinical laboratory field.

【0005】[0005]

【課題を解決するための手段】本発明者らは、これら従
来公知における酵素の欠点のないビリルビン・オキシダ
ーゼにつき、種々の研究をした結果、静岡県駿東郡長泉
町の土壌より分離した不完全菌でペニシリウム属に属す
る菌株M5613株が、ビリルビンおよび酸素からビリ
ルビンと水を生ずる反応を触媒するビリルビン・オキシ
ダーゼを産生し、かつこのビリルビン・オキシダーゼが
ビリルビンに基質特異性を示し、ビリベルジン、カテコ
ールおよびヘミン等には、基質特異性を示さないという
優れた特性を有する酵素であることを見出した。
The inventors of the present invention have conducted various studies on bilirubin oxidase, which is free from the drawbacks of these conventionally known enzymes, and as a result, an incomplete bacterium isolated from the soil of Nagaizumi-cho, Sunto-gun, Shizuoka Prefecture. Strain M5613 belonging to the genus Penicillium produces bilirubin oxidase which catalyzes the reaction of bilirubin and oxygen to produce bilirubin and water, and the bilirubin oxidase exhibits substrate specificity for bilirubin, and biliverdin, catechol, hemin, etc. Have found that the enzyme has an excellent property of not showing substrate specificity.

【0006】本発明は、上記知見に基づいて完成された
ものであって、ビリルビンに基質特異性を有し、少なく
とも、ビリベルジン、カテコールおよびヘミンに基質特
異性を有さず、2分子のビリルビンおよび1分子の酸素
から、2分子のビリベルジンと2分子の水を生ずる酵素
反応を触媒するビリルビン・オキシダーゼの使用法に関
するものである。すなわち、本発明は、被検体に、ビリ
ルビンに基質特異性を有し、少なくとも、ビリベルジ
ン、カテコールおよびヘミンに基質特異性を有さず、2
分子のビリルビンおよび1分子の酸素から2分子のビリ
ベルジンと2分子の水を生ずる酵素反応を触媒するビリ
ルビン・オキシダーゼを作用せしめ、被検体中のビリル
ビンを、ビルベルジンに変換し、生成するビリベルジン
の量または消費される酸素の量を測定してなる被検体中
のビリルビン量の測定法に関するものである。さらに本
発明は、検体に、ビリルビンに基質特異性を有し、少な
くとも、ビリベルジン、カテコールおよびヘミンに基質
特異性を有さず、2分子のビリルビンおよび1分子の酸
素から2分子のビリベルジンと2分子の水を生ずる酵素
反応を触媒するビリルビン・オキシダーゼを作用せし
め、検体中のビリルビンを消去する方法に関するもので
ある。
The present invention has been completed based on the above findings, and has a substrate specificity for bilirubin and at least no bispecific for biliverdin, catechol and hemin, and two molecules of bilirubin and The present invention relates to the use of bilirubin oxidase which catalyzes an enzymatic reaction that produces two molecules of biliverdin and two molecules of water from one molecule of oxygen. That is, according to the present invention, the analyte has a substrate specificity for bilirubin, and at least has no substrate specificity for biliverdin, catechol and hemin.
A bilirubin oxidase that catalyzes an enzymatic reaction that produces two molecules of biliverdin and two molecules of water from one molecule of bilirubin and one molecule of oxygen is caused to act, and bilirubin in a test substance is converted into viruverdin, and the amount of biliverdin produced or The present invention relates to a method for measuring the amount of bilirubin in a subject by measuring the amount of oxygen consumed. Furthermore, the present invention provides that a sample has a substrate specificity for bilirubin, and at least has no substrate specificity for biliverdin, catechol and hemin, and has two molecules of bilirubin and one molecule of oxygen and two molecules of biliverdin and two molecules. The present invention relates to a method for erasing bilirubin in a sample by causing bilirubin oxidase, which catalyzes the enzymatic reaction that produces water, to act.

【0007】本発明の新規なビリルビン・オキシダーゼ
生産菌の分類学的性状は以下の通りである。 I.各培地における生育状態 1.ツァベック寒天培地(Cz) 25℃の場合、生育は普通で、7日間で直径36〜40
mm。菌叢は平坦で綿毛状。淡黄色〔pale yel
low(Methuen 3A3)〕。浸出液は出さな
いか、出しても僅かで無色。拡散性色素は出さない。裏
面は灰黄色〔greyish yellow(4C
5)〕。
The taxonomical properties of the novel bilirubin oxidase-producing bacterium of the present invention are as follows. I. Growth condition in each medium 1. Czerbek agar (Cz) When grown at 25 ° C, the growth is normal and the diameter is 36-40 in 7 days.
mm. The flora is flat and fluffy. Pale yellow
low (Method 3A3)]. No leachate is produced, or a little colorless when it is released. Does not emit diffusible dyes. The back side is grayish yellow [4C
5)].

【0008】2.酵母エキス添加ツァベック寒天培地
(CYA) 25℃の場合、生育は速く、7日間で直径45〜49m
m。菌叢やや厚く綿毛状。放射状に4〜5条の皺を持
ち、淡赤色〔pale red(9A3)〕−緑灰色
〔greenish grey(27A3)〕が混合し
た状態。周辺部は全緑。浸出液は大粒で淡赤色〔pal
e red(9A3)〕。拡散性色素は淡赤色〔pal
e red(9A3)〕。裏面は紫褐色〔violet
brown(11E8)〕。
2. Yeast extract-containing Cavék agar (CYA) At 25 ° C, the growth is fast, and the diameter is 45 to 49 m in 7 days.
m. The flora is slightly thick and fluffy. It has 4 to 5 wrinkles in a radial pattern and is a mixture of pale red [pale red (9A3)]-green gray [greenish gray (27A3)]. The surrounding area is all green. The leachate is large and light red [pal
e red (9A3)]. Diffusible dye is pale red [pal
e red (9A3)]. The back side is purple brown [violet
brown (11E8)].

【0009】3.麦芽汁寒天培地(HA) 25℃の場合、生育は速く、7日間で直径48〜51m
m。菌叢は平坦で綿毛状。灰緑色〔greyish g
reen(29C3)〕。周辺部は全緑。浸出液および
拡散性色素は出さない。裏面はオリーブ褐色〔oliv
e brown(4D7)〕。
3. Wort agar medium (HA) At 25 ° C, the growth is fast and the diameter is 48 to 51 m after 7 days.
m. The flora is flat and fluffy. Gray green [greyish g
reen (29C3)]. The surrounding area is all green. No leachate or diffusible dye is produced. The back is olive brown [oliv
e brown (4D7)].

【0010】II. 生理的諸性状 生育し得るpH 1.5〜10.5 最適pH 3.5〜8.5 生育し得る温度 17〜37℃ 最適生育温度 28〜34℃II. Physiological properties Viable pH 1.5 to 10.5 Optimum pH 3.5 to 8.5 Viable temperature 17 to 37 ° C Optimal growth temperature 28 to 34 ° C

【0011】III.顕微鏡下における形態的特徴 有性世代は認められず、分生子により増殖。分生子柄
は、気中菌糸ないし気中菌糸から生じ、比較的長く、1
00〜250×2.0〜2.8μm、壁は滑面ないし僅
かに粗面。分生子形成様式はフィアロフォラ型。ペニシ
リンは単輪生ないし散開型。メトレは広角度に散開、1
1〜15×2.5〜2.8μm、2〜3本輪生、滑面な
いし僅かに粗面。フィアリドはトックリ型、7〜10×
2〜2.5μm、4〜7本輪生、分生子は亜球形ないし
楕円形で僅かに洋梨型が混在、2.3〜3.0×2.0
〜2.5μm、滑面ないし僅かに粗面。
III. Morphological characteristics under a microscope No sexual generation was observed, and the cells were proliferated by conidia. Conidia peduncles are derived from aerial hyphae or aerial hyphae and are relatively long.
00 to 250 × 2.0 to 2.8 μm, with smooth or slightly rough wall. Conidia formation is a filophora type. Penicillin is monocyclic or divergent. The metre spreads over a wide angle, 1
1 to 15 × 2.5 to 2.8 μm, 2 to 3 rings, smooth or slightly rough surface. Fear rid is a tokuri type, 7 to 10 ×
2 to 2.5 μm, 4 to 7 walnuts, conidia are subspherical or elliptical, and slightly pear-shaped mixed 2.3 to 3.0 × 2.0
~ 2.5 μm, smooth or slightly rough surface.

【0012】外生的な分生子を形成することから、M5
613株は不完全菌に属する。分生子形成様式はフィア
ロフォラ型で、フィアリドの先端から分生子を形成する
ことからペニシリウム(Penicillium)属に
属する。そこで、”Thegenus penicil
lium”Academic press.Londo
n p434(1979)および”A manual
of the penicillia”The wil
liams and Wilkins,Baltimo
re,p875(1949)を参照とし、さらに、ペニ
シリウムは単輪生ないし散開状、各培地での生育が速
く、CYAにおいて裏面が著しく紫褐色となる等の特色
から、ペニシリウム・ジャンシネラム(Penicil
liumjanthinellum)およびペニシリウ
ム・シンプリシシウム(Penicillium si
mplicissiumu)が挙げられるが、ペニシリ
ウム・シンプリシシウムは、分生子柄が400〜800
μmと長い、分生子柄の壁が粗面、裏面が紫褐色とはな
らない等から区別でき、M5613株は、ペニシリウム
・ジャンシネラム(P.janthinellum)と
同定された。尚、各培地における生育状態の色の表示は
Kornerup.A.and J.H.Wansch
er.1978.Methuen handbook
ofcolour.3rd ed.Eyre Meth
uen,Londonの表示法に従った。
From the formation of exogenous conidia, M5
Strain 613 belongs to an incomplete bacterium. The conidia is of the phialophora type and belongs to the genus Penicillium because it forms conidia from the tip of the fialid. So, "Thegenus penicil
ium "Academic press.Londo
n p434 (1979) and "A manual.
of the penicillia "The Will
liams and Wilkins, Baltimo
Re, p875 (1949). Furthermore, because Penicillium is a unicycle or divergent state, grows rapidly in each medium, and the rear surface of CYA is markedly purple-brown, Penicillium jancinerum (Penicillum) is used.
Lium janthinellum) and Penicillium simplicitium (Penicillium si)
mplicissium), but penicillium symplecticum has a conidia peduncle of 400-800.
It can be distinguished from the fact that the wall of conidia peduncle is rough and the back surface is not purple-brown, etc., and the M5613 strain was identified as Penicillium janthinellum. The color of the growth state in each medium is indicated by Kornerup. A. and J. H. Wansch
er. 1978. Methen handbook
ofcolor. 3rd ed. Eyer Meth
According to the notation of Uen and London.

【0013】なお、本菌株は工業技術院微生物生命工学
技術研究所にペニシリウム ジャンシネラムM5613
(Penicillium janthinellum
M5613)微工研菌第9167号(FERM P−
9167)として寄託されている。そして、本菌株はブ
タペスト条約に基づく寄託に移管され、微工研条寄第1
674号(FERM BP−1674)として寄託され
ている。
The strain of the present invention was found in Penicillium Jancineram M5613 at the Institute of Microbial Biotechnology, Institute of Industrial Science and Technology.
(Penicillium janthinellum
M5613) Micro Engineering Research Institute No. 9167 (FERM P-
9167). This strain was transferred to a deposit under the Budapest Treaty,
Deposited as 674 (FERM BP-1674).

【0014】本発明のビリルビン・オキシダーゼを生産
するに当たっては、このビリルビン・オキシダーゼ生産
菌を酵素などを生産する通常の方法で培養する。培養の
形態は、液体培養でも固体培養でもよいが、工業的には
ビリルビン・オキシダーゼ生産菌の細胞をその生産用培
地に接種し、深部通気攪拌培養を行うのが有利である。
ビリルビン・オキシダーゼを培養するための培地組成
は、微生物とくにペニシリウムの培養に通常用いられる
ものが広く使用される。
In producing the bilirubin oxidase of the present invention, the bilirubin oxidase-producing bacterium is cultured by a usual method for producing an enzyme and the like. The form of culture may be liquid culture or solid culture, but it is industrially advantageous to inoculate the production medium with cells of the bilirubin oxidase-producing bacterium and perform deep aeration agitation culture.
As a medium composition for culturing bilirubin oxidase, those commonly used for culturing microorganisms, particularly penicillium, are widely used.

【0015】窒素源として利用可能な窒素化合物であれ
ばよく、例えばコーン・スチープ・リカー、ペプトン、
カゼイン、大豆粉、酵母エキス、種々の肉エキスなどが
使用される。炭素源としては資化可能な炭素化合物であ
ればよく、例えば糖密、グルコース、シュクロース、デ
キストリンなどが使用される。その他馬鈴薯エキスも好
適な培地成分であり、また食塩、塩化カリウム、硫酸マ
グネシウム、第一リン酸カリウム、第二リン酸カリウム
等の種々の無機塩が必要に応じて使用される。培養温度
は菌が発育し、ビリルビン・オキシダーゼを生産する範
囲内で適宜変更し得るが、20〜37℃、好ましくは2
5〜30℃、特に28℃である。培養時間は、条件によ
つて多少異なるが、通常2〜8日、特に4日程度であ
る。しかしながら、ビリルビン・オキシダーゼが最高力
価に達する時期をみはからって適当な時期に培養を終了
するのは当然のことである。
Any nitrogen compound can be used as a nitrogen source, for example, corn steep liquor, peptone,
Casein, soybean flour, yeast extract, various meat extracts and the like are used. Any carbon compound that can be assimilated may be used as the carbon source, and for example, sugar condensate, glucose, sucrose, dextrin and the like are used. In addition, potato extract is also a suitable medium component, and various inorganic salts such as sodium chloride, potassium chloride, magnesium sulfate, potassium monophosphate, and dipotassium phosphate are used as necessary. The culturing temperature may be appropriately changed within a range in which the bacterium grows and produces bilirubin oxidase, but it is preferably 20 to 37 ° C., preferably 2
It is 5 to 30 ° C, especially 28 ° C. The culturing time varies depending on the conditions, but is usually 2 to 8 days, especially about 4 days. However, it is natural to terminate the culture at an appropriate time, considering the time when bilirubin oxidase reaches its maximum titer.

【0016】培養終了後、該培養物より本酵素を採取す
るには通常の酵素採取手段を用いることができる。な
お、本酵素は、菌体内および培養液相の両方に存在する
が、採取効率等の問題により、通常は、該培養物より菌
体を分別除去した培養液相より得るが、菌体内より酵素
を採取する通常の手段を用いて酵素を採取、培養液相よ
り得たものと合わせて用いてもよい。このようにして得
られた粗酵素液は、さらに公知の蛋白質、酵素などの単
離、精製手段を用いて精製し、精製されたビリルビン・
オキシダーゼが得られる。例えば、粗製のビリルビン・
オキシダーゼ含有液に、アセトン、メタノールなどの有
機溶媒による分別沈澱法、硫安、食塩、硫酸アルミニウ
ムなどによる塩析法などを用い溶液から酵素を沈澱せし
め、粗酵素を回収すればよい。
After culturing, the usual enzyme collecting means can be used to collect the present enzyme from the culture. Although the present enzyme is present in both the cells and the culture solution phase, it is usually obtained from the culture solution phase in which the cells are separated and removed from the culture due to problems such as collection efficiency. The enzyme may be collected using a usual means for collecting the enzyme, and used in combination with the enzyme obtained from the culture solution phase. The crude enzyme solution thus obtained is further purified by a known isolation and purification means for proteins, enzymes, etc.
An oxidase is obtained. For example, crude bilirubin
The crude enzyme may be recovered by precipitating the enzyme in the oxidase-containing solution using a fractional precipitation method using an organic solvent such as acetone or methanol, a salting-out method using ammonium sulfate, sodium chloride, aluminum sulfate or the like, and recovering the crude enzyme.

【0017】次いで、さらに必要に応じて精製するにあ
たって、この沈澱物を、トリス−塩酸緩衝液などの溶媒
に溶解し、これをカルボキシメチル−セルロース、カル
ボキシメチル−デキストランゲル、スルホプロピル−デ
キストランゲルなどのイオン交換樹脂やデキストランゲ
ルやポリアクリルアマイドゲルなどのゲル濾過剤による
吸着クロマトグラフイーを適宜組み合わせて行って精製
し、次いでこれを凍結乾燥等の手法を用い乾燥し、精製
ビリルビン・オキシダーゼを得る。このようにして得ら
れたビリルビン・オキシダーゼの理化学的性質は以下に
述べる通りである。
Then, for further purification, if necessary, the precipitate is dissolved in a solvent such as Tris-hydrochloric acid buffer solution, and this is dissolved in carboxymethyl-cellulose, carboxymethyl-dextran gel, sulfopropyl-dextran gel, etc. Ion-exchange resin and dextran gel or polyacryl amide gel, etc. are combined and purified by an appropriate combination of adsorption chromatography using gel filtration agents, and then dried by a technique such as freeze-drying to obtain purified bilirubin oxidase. . The physicochemical properties of the bilirubin oxidase thus obtained are as described below.

【0018】(1)活性測定法 基質溶液の調製:非抱合非結合型ビリルビン(和光純薬
社製)6mgを100mlビーカーに取り、5N Na
OH溶液0.5mlで湿らせ、1Mトリス−塩酸緩衝液
10mlを添加して良く混合し、水70mlを加えてp
Hを8.4に調製後、100mlにメスアップする。
(1) Method for measuring activity Preparation of substrate solution: 6 mg of unconjugated unbound bilirubin (manufactured by Wako Pure Chemical Industries, Ltd.) was placed in a 100 ml beaker and 5N Na was added.
Wet with 0.5 ml of OH solution, add 10 ml of 1M Tris-HCl buffer and mix well, add 70 ml of water and p.
After preparing H to 8.4, make up to 100 ml.

【0019】酵素溶液の調整:後述の実施例に基づき得
られたビリルビン・オキシダーゼ凍結乾燥品50mgを
正確に秤り取り、蒸留水65mlで溶解し、37℃に調
整した。 活性測定:基質溶液3mlを小試験管に取り37℃、水
浴中に2分間静置した後、酵素溶液0.1ml添加し、
反応を開始した。次に、正確に10分間、37℃で反応
した後に680nmにおける吸光度を分光光度計を用い
て測定した(A1 )、酵素溶液0.1mlの代わりに水
0.1mlを添加したものを対照として測定した
(A2 )。
Preparation of enzyme solution: 50 mg of lyophilized product of bilirubin oxidase obtained according to the examples described below was accurately weighed, dissolved in 65 ml of distilled water and adjusted to 37 ° C. Activity measurement: 3 ml of the substrate solution was placed in a small test tube and allowed to stand in a water bath at 37 ° C for 2 minutes, and then 0.1 ml of the enzyme solution was added,
The reaction was started. Next, after reacting exactly at 37 ° C. for 10 minutes, the absorbance at 680 nm was measured using a spectrophotometer (A 1 ), and 0.1 ml of water was added instead of 0.1 ml of the enzyme solution as a control. It was measured (A 2 ).

【0020】ビリルビン・オキシダーゼ活性(U/m
l) 11.9*1 :ビリベルジン2塩酸塩(シグマ社製、l
ot.43F−8020)8.3mgを1Mトリス−塩
酸緩衝液10mlで溶解し、水70mlを添加して5N
NaOH溶液を用いてpHを8.4に調整し、100
mlにメスアップした。これを0.1Mトリス−塩酸緩
衝液(pH8.4)を用いて2、5、10倍に希釈し、
750〜350nmの全吸収を分光度計(島津製作所社
製、UV−210A)を用いて測定した。図5に示した
ように、2倍に希釈したビリベルジン溶液の680nm
の吸光度は0.73、5倍に希釈したものは0.3、1
0倍に希釈したものは0.155の値を示した。これら
の結果からビリベルジンの1mM溶液の680nmにお
ける吸光度を11.9とした。
Bilirubin oxidase activity (U / m
l) 11.9 * 1 : biliverdin dihydrochloride (manufactured by Sigma, l
ot. 43F-8020) (8.3 mg) was dissolved in 1 M Tris-HCl buffer (10 ml), and water (70 ml) was added to the solution to give 5N.
Adjust the pH to 8.4 with NaOH solution and 100
Made up to ml. This was diluted 2, 5, 10 times with 0.1 M Tris-hydrochloric acid buffer (pH 8.4),
Total absorption at 750 to 350 nm was measured using a spectrophotometer (UV-210A, manufactured by Shimadzu Corporation). As shown in FIG. 5, the doubling diluted biliverdin solution at 680 nm
Absorbance is 0.73, 0.3-1 when diluted 5 times
The one diluted 0 times showed a value of 0.155. From these results, the absorbance of a 1 mM solution of biliverdin at 680 nm was set to 11.9.

【0021】(2)基質特異性:酸素電極計を用いて各
基質に対する特異性を酸素消費速度から検討した。この
時、基質溶液には0.1mMになるようにHgCl2
添加した。基質は、0.1mM、酵素は前述の活性測定
に用いた酵素液0.1mlを用いて行った結果、表1に
示す通り、ビリルビン以外の基質は反応を示さなかっ
た。それ故、本発明のビリルビン・オキシダーゼはビリ
ルビンに特異性が非常に高い。
(2) Substrate specificity: Specificity for each substrate was examined from the oxygen consumption rate using an oxygen electrode meter. At this time, HgCl 2 was added to the substrate solution to a concentration of 0.1 mM. The substrate was 0.1 mM, and the enzyme was 0.1 ml of the enzyme solution used for the above-described activity measurement. As a result, as shown in Table 1, substrates other than bilirubin did not react. Therefore, the bilirubin oxidase of the present invention has very high bilirubin specificity.

【0022】[0022]

【表1】 [Table 1]

【0023】(3)酵素作用:次の反応を触媒する。 ビリルビン + 1/2O2 → ビリベルジン +
2
(3) Enzymatic action: It catalyzes the following reaction. Bilirubin + 1 / 2O 2 → biliverdin +
H 2 O

【0024】(4)熱安定性:0.2Mリン酸カリウム
塩緩衝液(pH6.5)0.5mlに前述の酵素溶液
0.5mlを添加したものを40〜80℃各温度で30
分間づつ加熱し、活性測定法に基づいて残存活性を測定
した。その結果は、図1に示す通り50℃まで安定であ
った。
(4) Thermal stability: 0.5 M of 0.2 M potassium phosphate buffer (pH 6.5) to which 0.5 ml of the above enzyme solution was added was added at 40 to 80 ° C. at 30 ° C.
The mixture was heated for each minute, and the residual activity was measured based on the activity measuring method. The result was stable up to 50 ° C. as shown in FIG.

【0025】(5)至適温度:活性測定法における基質
溶液を用いて40〜70℃の各温度における本発明のビ
リルビン・オキシダーゼの活性を測定した結果は、図2
に示す通りで、至適温度は55〜60℃であった。
(5) Optimum temperature: The activity of the bilirubin oxidase of the present invention measured at each temperature of 40 to 70 ° C. using the substrate solution in the activity measurement method is shown in FIG.
As shown in, the optimum temperature was 55 to 60 ° C.

【0026】(6)pH安定性:前述の酵素溶液0.5
mlに0.2Mの各pH緩衝液を0.5mlづつ添加
し、70℃で30分間加温した後、この反応液を0.1
mlを活性測定法に基づいて残存活性を測定し、pHの
影響をしらべた。その結果は、図3に示す通りであり、
〔図中:緩衝液として酢酸緩衝液(pH4〜6)●−
●、リン酸カリウム塩緩衝液(pH6〜7)△−△、ト
リス−塩酸緩衝液(pH7〜8)○−○を示す〕、本発
明のビリルビン・オキシダーゼのpH安定性はpH4.
0〜4.5付近と認められた。
(6) pH stability: 0.5 of the above enzyme solution
0.5 ml of 0.2 M pH buffer was added to each ml, and the mixture was heated at 70 ° C. for 30 minutes, and the reaction mixture was added to 0.1 ml.
The residual activity was measured in ml based on the activity measuring method, and the influence of pH was examined. The result is as shown in FIG.
[In the figure: Acetate buffer (pH 4-6) as buffer ●-
●, potassium phosphate buffer (pH 6 to 7) △-△, Tris-hydrochloric acid buffer (pH 7 to 8) ○-○], pH stability of the bilirubin oxidase of the present invention is pH 4.
It was recognized as around 0 to 4.5.

【0027】(7)至適pH:活性測定法で作成した基
質溶液を5N HClあるいは5N NaOHを用いて
pH7.5、8.0、8.5、9.0、9.5、10に
調整し、これを用いて至適pHの測定を行った。ただ
し、pHの変動によってビリベルジンの吸光度が変化し
ないと仮定した。その結果は、図4に示す通りで、pH
8.5〜9.0に至適pHを有していた。
(7) Optimum pH: The substrate solution prepared by the activity measuring method was adjusted to pH 7.5, 8.0, 8.5, 9.0, 9.5, 10 with 5N HCl or 5N NaOH. Then, the optimum pH was measured using this. However, it was assumed that the absorbance of biliverdin was not changed by the change of pH. The results are shown in Fig. 4, and the pH
It had an optimum pH of 8.5 to 9.0.

【0028】(8)阻害および活性化:活性測定法に基
づいて基質溶液に金属イオン、EDTA、界面活性剤を
それぞれ1mM、1mMおよび0.05%添加し、ビリ
ルビン・オキシダーゼの活性を測定して、無添加時の活
性を100としたときの相対活性を求めた。その結果
は、表2に示す通りであって、水銀イオン、鉛イオン、
セチルトリメチルアンモニウムクロライドで著しく活性
化され、銅イオン、コバルトイオンで著しく阻害され
た。
(8) Inhibition and activation: The activity of bilirubin oxidase was measured by adding 1 mM, 1 mM and 0.05% of metal ion, EDTA and surfactant to the substrate solution based on the activity measurement method. The relative activity when the activity without addition was defined as 100 was determined. The results are shown in Table 2, and include mercury ions, lead ions,
It was markedly activated by cetyltrimethylammonium chloride and markedly inhibited by copper and cobalt ions.

【0029】(9)分子量:500,000±50,0
00(セフアデックスG−200によるゲル濾過法によ
る。分子量マーカ;カタラーゼ、フエリチン及びチログ
ロブリンを使用)。 (10)等電点:焦点電気泳動装置により測定した結果
は、pH4.7±0.5に等電点を有する。
(9) Molecular weight: 500,000 ± 50,0
00 (by gel filtration method using Sephadex G-200. Molecular weight marker; using catalase, ferritin and thyroglobulin). (10) Isoelectric point: The result measured by the focus electrophoresis apparatus has an isoelectric point at pH 4.7 ± 0.5.

【0030】[0030]

【表2】 1 ;セチルトリメチルアンモニウムクロリド *2 ;セチルトリメチルアンモニウムブロミド[Table 2] * 1 ; Cetyltrimethylammonium chloride * 2 ; Cetyltrimethylammonium bromide

【0031】(11)Km値:ビリルビン標品(和光純
薬社製)を2、4、6、8、10、15、20mgと
り、活性測定法の基質溶液の調整に基づいて溶解し、前
述の活性測定に用いた酵素溶液0.1mlを用いてKm
値を測定した結果、本測定条件下でビリルビンに対する
Km値は、1.1×10-4Mであった。 以上の諸性質を公知のビリルビン・オキシダーゼと比較
すると、いずれの酵素とも異なることが判る。
(11) Km value: 2,4,6,8,10,15,20 mg of a bilirubin standard product (manufactured by Wako Pure Chemical Industries, Ltd.) was taken and dissolved according to the adjustment of the substrate solution in the activity measuring method, Km using 0.1 ml of the enzyme solution used to measure the activity of
As a result of measuring the value, the Km value for bilirubin under this measurement condition was 1.1 × 10 −4 M. Comparing these properties with known bilirubin oxidase, it is clear that they are different from any of the enzymes.

【0032】本発明のビリルビン・オキシダーゼを用い
て被検体中のビリルビン量を測定するには、公知のビリ
ルビン測定法が適応可能である。即ち被検体試料中のビ
リルビンを本発明のビリルビン・オキシダーゼの作用に
よりビリルベルジンに変換せしめ、生成するビリベルジ
ン量または反応において消費される酸素量を測定するこ
とによつて、被検体中のビリルビン量を測定することが
きる。
In order to measure the amount of bilirubin in a sample using the bilirubin oxidase of the present invention, known bilirubin measuring methods can be applied. That is, the amount of bilirubin in the test sample is measured by converting bilirubin in the test sample into bilirubin by the action of the bilirubin oxidase of the present invention, and measuring the amount of biliverdin produced or the amount of oxygen consumed in the reaction. I can do it.

【0033】検体中のビリルビンの濃度を測定する場合
において、用いられる本発明ビリルビン・オキシダーゼ
の量は、ビリルビン・オキシダーゼ活性として、0.0
1〜10単位であるが、測定時間に応じて適宜調節すれ
ばよく、ドデシル硫酸ナトリウム、コール酸ナトリウ
ム、フェリシアン化カリウム等の反応促進物質およびそ
の他緩衝液、酵素の安定化剤などは、必要に応じて加え
ればよい。
When the concentration of bilirubin in a sample is measured, the amount of the bilirubin oxidase of the present invention used is 0.02 as the bilirubin oxidase activity.
Although it is 1 to 10 units, it may be appropriately adjusted according to the measurement time, and reaction accelerating substances such as sodium dodecyl sulfate, sodium cholate, potassium ferricyanide, etc. and other buffers, enzyme stabilizers, etc. may be used as necessary. All you have to do is add.

【0034】また、検体中の抱合型ビリルビンおよび非
抱合型ビリルビンを分別測定する場合においても公知の
方法に、本発明ビリルビン・オキシダーゼを適用すれば
よく、例えば抱合型ビリルビンはpH6未満で分析を行
うことによつて検出でき、総ビルリビン量は、pH6〜
10で分析を行うことができ、非抱合型ビリルビンは、
総ビリルビン量から抱合型ビリルビン量を減じることに
よつて求められる。
Further, in the case of separately measuring conjugated bilirubin and unconjugated bilirubin in a sample, the bilirubin oxidase of the present invention may be applied to a known method. For example, conjugated bilirubin is analyzed at a pH of less than 6. The total amount of bilribin can be detected by
The unconjugated bilirubin can be analyzed in 10
It is determined by subtracting the amount of conjugated bilirubin from the total amount of bilirubin.

【0035】さらに、本発明ビリルビン・オキシダーゼ
を適宜添加することにより、臨床診断における検体中の
ビリルビン以外の他の物質を測定する系、たとえばグル
コース測定において、グルコース・オキシダーゼ−パー
オキシダーゼを用いる系、コレステロール測定におい
て、コステロール・オキシダーゼ−パーオキシダーゼを
用いる系等において、測定物質であるビリルビンを消去
することができる。
Furthermore, by appropriately adding the bilirubin oxidase of the present invention, a system for measuring a substance other than bilirubin in a sample in clinical diagnosis, for example, a system using glucose oxidase-peroxidase in glucose measurement, cholesterol, In the measurement, bilirubin, which is a measurement substance, can be eliminated in a system using costerol oxidase-peroxidase and the like.

【0036】以下に本発明の実施例および参考例を挙げ
る。ただし、本発明はこれら実施例および参考例に限定
されるものでないことはいうまでもない。 参考例 1 馬鈴薯の皮むき薄切り200gに蒸留水1リットルを添
加し、1時間煮沸後、布で濾過した上清にブドウ糖20
g、酵母エキス1.5g、KH2 PO4 2.0g、Mg
SO4 ・7H2 O 0.5gを添加し、溶解後蒸留水を
加え1リットルにした。本培養液100mlを500m
l三角フラスコに分注し、121℃、20分間加熱滅菌
した。これにペニシリウム・ジャンシネラム M561
3(FERM BP−1674)の保存寒天斜面培地よ
り1白金耳を接種し、28℃にて4日間振とう培養し
た。
Examples and reference examples of the present invention will be given below. However, it goes without saying that the present invention is not limited to these examples and reference examples. Reference Example 1 To 200 g of sliced potatoes, 1 liter of distilled water was added, and after boiling for 1 hour, 20 g of glucose was added to the supernatant filtered with a cloth.
g, yeast extract 1.5 g, KH 2 PO 4 2.0 g, Mg
It was added SO 4 · 7H 2 O 0.5g, and 1 liter added after dissolution of distilled water. 500 ml of 100 ml of main culture
The mixture was dispensed into an Erlenmeyer flask and sterilized by heating at 121 ° C. for 20 minutes. To this Penicillium Jancineram M561
3 platinum (FERM BP-1674) was inoculated with 1 platinum loop from the preserved agar slant medium, and shake-cultured at 28 ° C. for 4 days.

【0037】培養液10mlを20分間、3℃、15K
Hzの音波処理を行い菌体を破壊した。これを5回繰り
返し行い50mlの粗酵素液を得た(20u)。これを
20分間、5℃、15,000r.p.m.で遠心分離
した上清を1N塩酸を用いてpH5.0に調整し、20
分間、5℃、15,000r.p.m.で遠心分離し
た。この沈澱を20mMリン酸カリウム塩緩衝液(pH
6.5)50mlで溶解し、20分間、15,000
r.p.m.で遠心分離し、上清を得た(11.3
u)。この5mlを20mMリン酸カリウム塩緩衝液
(pH6.5)で緩衝化したセファデックスG−100
(2.8×60cm)カラムを用いてゲル濾過を行っ
た。これを10回繰り返し、50mlの酵素溶液を得た
(7.2u)。これに100mgのサッカロースを添加
し、常法に基づいて凍結乾燥し、0.018u/mgの
凍結乾燥品を320mg得た。
10 ml of culture broth for 20 minutes at 3 ° C. and 15K
The cells were sonicated to destroy the cells. This was repeated 5 times to obtain 50 ml of crude enzyme solution (20u). This was kept for 20 minutes at 5 ° C. and 15,000 rpm. p. m. The pH of the supernatant after centrifugation was adjusted to 5.0 with 1N hydrochloric acid,
Minutes, 5 ° C., 15,000 r. p. m. And centrifuged. This precipitate was added to 20 mM potassium phosphate buffer (pH
6.5) Dissolve in 50 ml, 20 minutes, 15,000
r. p. m. Centrifugation was carried out with to obtain a supernatant (11.3
u). Sephadex G-100 obtained by buffering 5 ml of this with 20 mM potassium phosphate buffer (pH 6.5)
Gel filtration was performed using a (2.8 x 60 cm) column. This was repeated 10 times to obtain 50 ml of enzyme solution (7.2 u). To this, 100 mg of sucrose was added, and freeze-dried according to a conventional method to obtain 320 mg of a freeze-dried product of 0.018 u / mg.

【0038】実施例 1 前記活性測定法・基質溶液の調製に従って作成した基質
溶液3mlを、3ml容石英セルに取り、10mM H
gCl2 を30μl添加した。これに実施例1により得
たビリルビン・オキシダーゼ凍結乾燥品を50mg正確
に秤り取り、蒸留水6.5mlで溶解したビリルビン・
オキシダーゼ溶液を50μl、及び100μl添加し、
分光光度計(島津製作所社製、UV−210A)にセッ
トし、37℃で680nmにおける吸光度の経時変化を
チャートに描いた(図6)。図6から明らかなように、
50μlの酵素液を使用すると6分でビリルビン・オキ
シダーゼの反応は終了し、100μlの酵素液を使用す
ると、3.5分で反応は終了した。これから本条件下で
は短時間でビリルビンの測定を、ビリベルジンの生成を
測定することで可能となり、またビリルビンの消去も基
質特異性が高いことから他の粗製物に影響を及ぼしにく
い条件で可能となった。
Example 1 3 ml of the substrate solution prepared according to the above-mentioned activity measuring method / preparation of substrate solution was placed in a 3 ml volume quartz cell and 10 mM H 2
30 μl of gCl 2 was added. To this, 50 mg of the lyophilized product of bilirubin oxidase obtained in Example 1 was accurately weighed and dissolved in 6.5 ml of distilled water.
Add 50 μl and 100 μl of oxidase solution,
The sample was set on a spectrophotometer (UV-210A, manufactured by Shimadzu Corporation), and the change with time of the absorbance at 680 nm at 37 ° C was drawn on a chart (Fig. 6). As is clear from FIG.
When 50 μl of the enzyme solution was used, the reaction of bilirubin oxidase was completed in 6 minutes, and when 100 μl of the enzyme solution was used, the reaction was completed in 3.5 minutes. From this, it is possible under this condition to measure bilirubin in a short time by measuring the production of biliverdin, and elimination of bilirubin is also possible under conditions that do not affect other crude products due to its high substrate specificity. It was

【0039】実施例 2 人血清を0.1、0.2、0.3、0.4、0.5、
0.6、0.7mlそれぞれ分取し、ここに0.1Mト
リス−塩酸緩衝液を加えて3mlとし、本発明ビリルビ
ン・オキシダーゼ0.1Uを添加し、37℃、30分間
インキュベートし、その反応液について分光光度計(島
津製作所社製、UV−210A)にセットし、37℃で
680nmにおける吸光度を測定した。その結果を図7
に示すが、種々の割合に希釈した血清溶液において極め
て良好な直線性が得られた。
Example 2 Human sera of 0.1, 0.2, 0.3, 0.4, 0.5,
0.6 and 0.7 ml of each was taken, 0.1 M Tris-hydrochloric acid buffer was added to make 3 ml, and 0.1 U of the bilirubin oxidase of the present invention was added, followed by incubation at 37 ° C. for 30 minutes, and the reaction The liquid was set in a spectrophotometer (UV-210A, manufactured by Shimadzu Corporation), and the absorbance at 680 nm was measured at 37 ° C. The result is shown in FIG.
As shown in Table 1, extremely good linearity was obtained in serum solutions diluted with various ratios.

【0040】実施例 3 検量線の作成 (1)試液の調整: 緩衝液 :0.1Mトリス−塩酸緩衝液(pH8.
4) 酵素反応液:0.1Mトリス−塩酸緩衝液(pH8.
4)に本発明ビリルビン・オキシダーゼを0.1U/テ
ストの割合で添加して調整した。 (2)標準ビリルビン溶液の調整:非抱合型非結合型ビ
リルビン(和光純薬社製)5.9mgを正確に秤り取
り、5N NaOH溶液0.5mlで湿らせ、1Mトリ
ス−塩酸緩衝液(pH8.4)10mlで溶かした後、
100mlにメスアップしたものを、100μMビリル
ビン溶液とし、これを0.1Mトリス−塩酸緩衝液(p
H8.4)で希釈して、2、4、6、8、10、14μ
Mの標準ビリルビン溶液を調整した。
Example 3 Preparation of calibration curve (1) Preparation of test solution: Buffer solution: 0.1 M Tris-hydrochloric acid buffer solution (pH 8.
4) Enzyme reaction solution: 0.1 M Tris-hydrochloric acid buffer solution (pH 8.
The bilirubin oxidase of the present invention was added to 4) at a rate of 0.1 U / test for adjustment. (2) Preparation of standard bilirubin solution: Accurately weigh 5.9 mg of unconjugated unbound bilirubin (manufactured by Wako Pure Chemical Industries, Ltd.), moisten it with 0.5 ml of 5N NaOH solution, and 1M Tris-hydrochloric acid buffer solution ( After dissolving with 10 ml of pH 8.4),
The solution diluted to 100 ml was used as a 100 μM bilirubin solution, which was used as a 0.1 M Tris-hydrochloric acid buffer solution (p.
H8.4) and diluted to 2,4,6,8,10,14μ
M standard bilirubin solution was prepared.

【0041】(3)上記の標準ビリルビン溶液をそれぞ
れ3mlづつに、上記酵素反応液を添加し、37℃、3
0分間インキュベートし、その反応液について、分光光
度計(島津製作所社製、UV−210A)にセットし、
37℃で680nmにける吸光度を測定した。その結果
を図8に示すが、極めて良好な直線性を示した。
(3) The above enzyme reaction solution was added to 3 ml each of the above standard bilirubin solution, and the mixture was kept at 37 ° C. for 3 minutes.
After incubating for 0 minutes, the reaction solution was set in a spectrophotometer (UV-210A manufactured by Shimadzu Corporation),
The absorbance at 680 nm was measured at 37 ° C. The results are shown in FIG. 8, which showed extremely good linearity.

【0042】[0042]

【発明の効果】本発明のビリルビン・オキシダーゼはビ
リルビンに基質特異性を有し、肝疾患の診断に有利であ
り、また、臨床診断における検体中のビリルビンが他の
物質の測定における阻害となる場合において、ビリルビ
ンの消去に有用であり、更に活性も非常に高いので屎尿
処理水の脱色への利用が期待される。
INDUSTRIAL APPLICABILITY The bilirubin oxidase of the present invention has a substrate specificity for bilirubin, is advantageous for diagnosing liver diseases, and when bilirubin in a sample in clinical diagnosis becomes an inhibition in the measurement of other substances. , It is useful for the elimination of bilirubin and has a very high activity, and therefore it is expected to be used for decolorization of treated human waste water.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明のビリルビン・オキシダーゼの熱安定性
を示すものである。
FIG. 1 shows the thermostability of bilirubin oxidase of the present invention.

【図2】本発明のビリルビン・オキシダーゼの至適温度
を示すものである。
FIG. 2 shows the optimum temperature of bilirubin oxidase of the present invention.

【図3】本発明のビリルビン・オキシダーゼのpH安定
性を示すものである。
FIG. 3 shows pH stability of the bilirubin oxidase of the present invention.

【図4】本発明のビリルビン・オキシダーゼの至適pH
を示すものである。
FIG. 4 Optimum pH of bilirubin oxidase of the present invention
It shows.

【図5】ビリベルジンの吸収曲線を示すものである。FIG. 5 shows the absorption curve of biliverdin.

【図6】本発明のビリルビン・オキシダーゼの反応経過
を示すものである。
FIG. 6 shows the reaction course of bilirubin oxidase of the present invention.

【図7】本発明の酵素を用いて血液試料量と活性の相関
図を示すものである。
FIG. 7 shows a correlation diagram between the amount of blood sample and the activity using the enzyme of the present invention.

【図8】ビリルビンの検量線である。FIG. 8 is a calibration curve for bilirubin.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 被検体に、ビリルビンに基質特異性を有
し、少なくとも、ビリベルジン、カテコールおよびヘミ
ンに基質特異性を有さず、2分子のビリルビンおよび1
分子の酸素から2分子のビリベルジンと2分子の水を生
ずる酵素反応を触媒するビリルビン・オキシダーゼを作
用せしめ、被検体中のビリルビンを、ビルベルジンに変
換し、生成するビリベルジンの量または消費される酸素
の量を測定してなる被検体中のビリルビン量の測定法。
1. A test sample having a substrate specificity for bilirubin and at least no substrate specificity for biliverdin, catechol and hemin, and two molecules of bilirubin and 1
The bilirubin oxidase, which catalyzes an enzymatic reaction that produces two molecules of biliverdin and two molecules of water from molecular oxygen, is made to act, and the bilirubin in the test substance is converted to bilberdin, and the amount of biliverdin produced or the amount of consumed oxygen is changed. A method for measuring the amount of bilirubin in a subject by measuring the amount.
【請求項2】 検体に、ビリルビンに基質特異性を有
し、少なくとも、ビリベルジン、カテコールおよびヘミ
ンに基質特異性を有さず、2分子のビリルビンおよび1
分子の酸素から2分子のビリベルジンと2分子の水を生
ずる酵素反応を触媒するビリルビン・オキシダーゼを作
用せしめ、検体中のビリルビンを消去する方法。
2. A specimen has a substrate specificity for bilirubin, and at least has no substrate specificity for biliverdin, catechol and hemin, and has two molecules of bilirubin and 1 molecule.
A method of erasing bilirubin in a sample by causing bilirubin oxidase, which catalyzes an enzymatic reaction that produces two molecules of biliverdin and two molecules of water, from oxygen of a molecule to act.
JP8189379A 1996-07-18 1996-07-18 Assay using a novel bilirubin oxidase Expired - Fee Related JP2901231B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8189379A JP2901231B2 (en) 1996-07-18 1996-07-18 Assay using a novel bilirubin oxidase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8189379A JP2901231B2 (en) 1996-07-18 1996-07-18 Assay using a novel bilirubin oxidase

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP62144964A Division JP2578430B2 (en) 1987-06-10 1987-06-10 New bilirubin. Oxidase and method for producing the same

Publications (2)

Publication Number Publication Date
JPH0919298A true JPH0919298A (en) 1997-01-21
JP2901231B2 JP2901231B2 (en) 1999-06-07

Family

ID=16240338

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8189379A Expired - Fee Related JP2901231B2 (en) 1996-07-18 1996-07-18 Assay using a novel bilirubin oxidase

Country Status (1)

Country Link
JP (1) JP2901231B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1146795A (en) * 1997-08-04 1999-02-23 Iatron Lab Inc Oxidase-containing reagent for analysis
CN100378584C (en) * 2002-11-18 2008-04-02 村田机械株式会社 Image forming device

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1146795A (en) * 1997-08-04 1999-02-23 Iatron Lab Inc Oxidase-containing reagent for analysis
CN100378584C (en) * 2002-11-18 2008-04-02 村田机械株式会社 Image forming device

Also Published As

Publication number Publication date
JP2901231B2 (en) 1999-06-07

Similar Documents

Publication Publication Date Title
JPS61104784A (en) Production of peroxidase
FR2491951A1 (en) METHOD FOR DETERMINING AMYLASE ACTIVITY
JP2578430B2 (en) New bilirubin. Oxidase and method for producing the same
FR2555197A1 (en) NOVEL MALTOSE DEHYDROGENASE, PRODUCTION THEREOF, METHOD OF ANALYSIS USING THE SAME, AND COMPOSITION USED THEREFOR
JPS6122952B2 (en)
TW201918551A (en) Myrmecridium flexuosum NUK-21, novel lactose oxidase produced by myrmecridium flexuosum NUK-21, and method of conversion into lactobionic acid
WO1980000454A1 (en) Method of measuring substrate of xanthine oxidase,and composition for the determination
JP2001245657A (en) New microbial cell for producing aldonic acid and its enzyme
JPH0324200B2 (en)
JP3041840B2 (en) Novel glycerol dehydrogenase, its production method and its use
JP2788174B2 (en) Novel creatine amidinohydrolase and method for producing the same
WO1997031103A1 (en) Method for determining 1,5-anhydroglucitol
JP2901231B2 (en) Assay using a novel bilirubin oxidase
JP4511655B2 (en) Sorbitol dehydrogenase, microorganism producing the same, and method for producing the same
JP2000135079A (en) 1,5-anhydroglucitol dehydrogenase
US5100795A (en) Bile acid sulfate sulfatase, process for its preparation and method for assaying bile acid
TWI752463B (en) Oligosaccharide oxidase, preparing method thereof and method of conversion into chito-oligochitosan acid
JPH0249720B2 (en)
JP3031517B2 (en) Novel ascorbate oxidase, its production method and its use
JPS6314692A (en) 3alpha-hydroxysteroid oxidase and method for determining 3alpha-hydroxysteroid using same
JP3778603B2 (en) Sorbitol oxidase, its production method and its use
JP3532937B2 (en) Novel NADPH-dependent diaphorase having high heat resistance and method for producing the same
JP3862034B2 (en) Method for measuring glucose
JP2886846B2 (en) 1,5-anhydroglucitol dehydrogenase and method for producing the same
WO1997036997A1 (en) Novel bile acid converting microorganism and process for preparing bile acid

Legal Events

Date Code Title Description
A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 19971224

LAPS Cancellation because of no payment of annual fees